- Minerva Neurosciences named Jim O’Connor Chief Business Officer, effective April 21, 2026.
- O’Connor will also serve as General Counsel.
- President Geoff Race will leave company, remaining involved as a consultant.
- Race joined Minerva in 2010, serving in roles including Chief Financial Officer and Chief Business Officer before becoming President.
- Executive Chairman and CEO Remy Luthringer said O’Connor will help advance roluperidone toward next planned Phase 3 trial.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Minerva Neurosciences Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202604021605OMX_____CNEWS_EN_GNW9683626_en) on April 02, 2026, and is solely responsible for the information contained therein.
Comments